IL200528A0 - Methods of treating ophthalmic diseases - Google Patents

Methods of treating ophthalmic diseases

Info

Publication number
IL200528A0
IL200528A0 IL200528A IL20052809A IL200528A0 IL 200528 A0 IL200528 A0 IL 200528A0 IL 200528 A IL200528 A IL 200528A IL 20052809 A IL20052809 A IL 20052809A IL 200528 A0 IL200528 A0 IL 200528A0
Authority
IL
Israel
Prior art keywords
methods
ophthalmic diseases
treating ophthalmic
treating
diseases
Prior art date
Application number
IL200528A
Other languages
English (en)
Original Assignee
Rinat Neuroscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rinat Neuroscience Corp filed Critical Rinat Neuroscience Corp
Publication of IL200528A0 publication Critical patent/IL200528A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL200528A 2007-03-09 2009-08-20 Methods of treating ophthalmic diseases IL200528A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89418107P 2007-03-09 2007-03-09
US12/041,581 US20090022728A1 (en) 2007-03-09 2008-03-03 Methods of treating ophthalmic diseases
PCT/IB2008/000486 WO2008110885A2 (en) 2007-03-09 2008-03-06 Methods of treating ophthalmic diseases

Publications (1)

Publication Number Publication Date
IL200528A0 true IL200528A0 (en) 2010-04-29

Family

ID=39760152

Family Applications (1)

Application Number Title Priority Date Filing Date
IL200528A IL200528A0 (en) 2007-03-09 2009-08-20 Methods of treating ophthalmic diseases

Country Status (15)

Country Link
US (1) US20090022728A1 (ko)
EP (1) EP2134751A2 (ko)
JP (2) JP5964004B2 (ko)
KR (2) KR101259225B1 (ko)
CN (2) CN101687922B (ko)
AU (1) AU2008224600B2 (ko)
BR (1) BRPI0808711A2 (ko)
CA (1) CA2680222C (ko)
HK (1) HK1201046A1 (ko)
IL (1) IL200528A0 (ko)
MX (1) MX2009009636A (ko)
NZ (1) NZ579273A (ko)
RU (1) RU2434639C2 (ko)
TW (1) TWI449535B (ko)
WO (1) WO2008110885A2 (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DK1976877T4 (en) 2005-11-30 2017-01-16 Abbvie Inc Monoclonal antibodies to amyloid beta protein and uses thereof
KR20080090408A (ko) 2005-11-30 2008-10-08 아보트 러보러터리즈 항-Ａβ 글로불로머 항체, 이의 항원-결합 잔기, 상응하는하이브리도마, 핵산, 벡터, 숙주 세포, 당해 항체의 제조방법, 당해 항체를 포함하는 조성물, 당해 항체의 용도 및당해 항체의 사용 방법
PL2046833T3 (pl) 2006-07-14 2014-01-31 Ac Immune Sa Humanizowane przeciwciało przeciw amyloidowi beta
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
US8048420B2 (en) 2007-06-12 2011-11-01 Ac Immune S.A. Monoclonal antibody
US8613923B2 (en) 2007-06-12 2013-12-24 Ac Immune S.A. Monoclonal antibody
NZ601858A (en) * 2007-10-05 2014-03-28 Genentech Inc Methods and compositions for diagnosis and treatment of amyloidosis
AU2015200604B2 (en) * 2007-10-05 2016-10-27 Ac Immune S.A. Use of anti-amyloid beta antibody in ocular diseases
CA2701790A1 (en) * 2007-10-05 2009-04-16 Ac Immune S.A. Use of humanized anti-beta-amyloid antibody in ocular diseases
US9403902B2 (en) * 2007-10-05 2016-08-02 Ac Immune S.A. Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody
PE20091449A1 (es) * 2007-12-11 2009-10-07 Glaxo Group Ltd Proteinas de union a antigenos
JP2013523182A (ja) 2010-04-15 2013-06-17 アボット・ラボラトリーズ アミロイドベータ結合タンパク質
JP6081356B2 (ja) 2010-07-30 2017-02-15 エーシー イミューン エス．エー． 安全で機能的なヒト化抗βアミロイド抗体
CN105348387B (zh) 2010-08-14 2020-08-25 Abbvie 公司 β淀粉样蛋白结合蛋白
US20140050733A1 (en) 2011-02-07 2014-02-20 Dale B. Schenk Apoe immunotherapy
RU169012U1 (ru) * 2016-08-08 2017-03-01 Дмитрий Викторович Давыдов Электрод для электростимуляции зрительного нерва и зрительных путей и контроля физиологических параметров орбитальных структур глаза
WO2018200620A1 (en) * 2017-04-25 2018-11-01 National Cheng Kung University Use of il-20 antagonists for treating eye diseases
MX2022007114A (es) * 2019-12-09 2022-07-11 Alexion Pharma Inc Polipeptidos de fosfatasa alcalina y metodos de uso de los mismos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005025516A2 (en) * 2003-09-12 2005-03-24 The Regents Of The University Of California Monoclonal antibodies specific for conformational epitopes of prefibrillar aggregates
EP1633786A4 (en) * 2002-10-09 2007-07-25 Rinat Neuroscience Corp METHOD FOR TREATING ALZHEIMER DISEASE WITH ANTIBODIES TO AMYLOID BETA PEPTIDE AND COMPOSITIONS THEREOF
US20060121039A1 (en) * 2004-12-07 2006-06-08 Alcon, Inc. Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration
EP2298807A3 (en) * 2004-07-30 2011-05-18 Rinat Neuroscience Corp. Antibodies directed against amyloid-beta peptide and methods using same
WO2006039327A2 (en) * 2004-10-01 2006-04-13 Merck & Co., Inc. Methods of treatment or prophylaxis of amyloidogenic diseases of the eye or optic nerve
AU2006211625A1 (en) * 2005-01-14 2006-08-10 The Regents Of The University Of California Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders
UY29504A1 (es) * 2005-04-29 2006-10-31 Rinat Neuroscience Corp Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
RU2551782C2 (ru) * 2005-12-12 2015-05-27 Ац Иммуне Са Специфические в отношении амилоида бета (а бета) 1-42 моноклональные антитела, обладающие терапевтическими свойствами
PL2046833T3 (pl) * 2006-07-14 2014-01-31 Ac Immune Sa Humanizowane przeciwciało przeciw amyloidowi beta
EP2074145B1 (en) * 2006-10-02 2017-08-16 AC Immune S.A. Humanized antibody against amyloid beta

Also Published As

Publication number Publication date
CA2680222A1 (en) 2008-09-18
CN101687922B (zh) 2014-06-11
KR101259225B1 (ko) 2013-04-30
TWI449535B (zh) 2014-08-21
JP2009062358A (ja) 2009-03-26
MX2009009636A (es) 2009-12-11
CA2680222C (en) 2013-10-08
CN101687922A (zh) 2010-03-31
NZ579273A (en) 2012-03-30
RU2009133789A (ru) 2011-03-20
KR20090119990A (ko) 2009-11-23
EP2134751A2 (en) 2009-12-23
WO2008110885A3 (en) 2009-01-15
BRPI0808711A2 (pt) 2014-08-12
WO2008110885A2 (en) 2008-09-18
AU2008224600B2 (en) 2011-09-29
AU2008224600A1 (en) 2008-09-18
TW200900079A (en) 2009-01-01
CN104027803A (zh) 2014-09-10
US20090022728A1 (en) 2009-01-22
RU2434639C2 (ru) 2011-11-27
KR20120054105A (ko) 2012-05-29
HK1201046A1 (en) 2015-08-21
JP2015038109A (ja) 2015-02-26
JP5964004B2 (ja) 2016-08-03

Similar Documents

Publication Publication Date Title
HK1201046A1 (en) Methods of treating ophthalmic diseases
HK1158172A1 (en) Compounds for treating ophthalmic diseases and disorders
HK1217763A1 (zh) 用於治療疾病的方法
EP2432476A4 (en) METHOD FOR THE TREATMENT OR PREVENTION OF EYE DISEASES
EP2182983A4 (en) TREATMENT OF AMYLOIDOGENIC DISEASES
EP2176283A4 (en) METHOD AND COMPOSITIONS FOR TREATING BRAIN DISEASES
PT2044111E (pt) Abordagem seletiva do fator h do complemento para o tratamento de doenças
EP2134173A4 (en) TREATMENT OF DISEASES SIGNED BY IGNITION
PL2056863T3 (pl) Leczenie chorób oczu
EP2509596A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF EYE DISEASES
IL207687A0 (en) Method of treating ocular diseases by gene therapy
GB0915259D0 (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders
IL204728A0 (en) Methods and compounds for treating retinol-related diseases
EP2341936A4 (en) METHOD FOR TREATING OR PREVENTING IL-1ß-CONTAINED ILLNESSES
EP2026822A4 (en) TOPICAL TREATMENT FOR EYE SURGERY DISEASES
HK1149545A1 (en) Compositions and methods for treating ophthalmic diseases
EP2403503A4 (en) METHOD FOR THE TREATMENT OF EYE IGNITIONS
PL2380585T3 (pl) Sposoby leczenia chorób autoimmunologicznych
HK1139334A1 (en) Method of treating demyelination diseases
EP2296682B8 (en) Methods of treating ophthalmic disorders
EP2164494A4 (en) Methods of Treatment
EP2262515A4 (en) USE OF BLACK SOY TO TREAT OPHTHALMIC DISEASES
EP2244702A4 (en) TREATMENT OF NEURAL DISEASES OR NEURAL CONDITIONS
EP2117529A4 (en) METHODS FOR TREATING DISEASES HAVING ALTERED IGE REGULATION
ZA200906883B (en) Methods of treating ophthalmic diseases